People Michael D. Kaminski Stephen B. Maebius Kristel Schorr Industry Teams Life Sciences Life Sciences Collaborations & Licensing Practice Areas Chemical, Biotechnology & Pharmaceutical IP Due Diligence Japan Offices Tokyo Washington, D.C. Due Diligence for In-Licensing Anemia Drug Licensing of biotechnology drug with up-front payment of $100 million. Represented acquiring company, a global pharmaceutical company, in IP diligence and drafting transaction agreements. Related 1 2 3